POET Stock Jumped on $500 Million Deal With Lumilens. Its Financials Have a Long Way to Go.

Announcing a deal is mostly viewed as a positive for a company. Yet, when Poet Technologies (POET) revealed that it had signed a $500 million deal with photonics-focused company, Lumilens, there must have been some in the market who believed that there could be a correction in the stock. However, there was no repeat of…


POET Stock Jumped on 0 Million Deal With Lumilens. Its Financials Have a Long Way to Go.

Announcing a deal is mostly viewed as a positive for a company. Yet, when Poet Technologies (POET) revealed that it had signed a $500 million deal with photonics-focused company, Lumilens, there must have been some in the market who believed that there could be a correction in the stock.

However, there was no repeat of the Marvell (MRVL) episode, and Poet shares ended yesterday’s trading session up a whopping 43%. The partnership aims to combine Poet’s expertise in developing wafer-level photonic integration platforms and Lumilens’s optical chipsets and advanced manufacturing capabilities to build advanced optical engines for AI data centers.

More News from Barchart

About Poet Technologies

Tracing its roots back to 1972, but operating in its current avatar since the 2010s, Poet Technologies develops photonic integrated solutions, optical engines, and data center optical interconnect technology.

Valued at a market cap of $2.7 billion, POET stock’s rise this year has been akin to a rap song, up by 180% on a YTD basis.

www.barchart.com
www.barchart.com

However, the last month has been tumultuous for the company, with many attributing to it the moniker of a meme stock.

First, the company faced issues regarding its tax status. Domiciled in Canada, Poet operates as a passive foreign investment company, or PFIC, in the United States. A short-seller report by investment research firm Wolfpack said that numerous IRS penalties could be triggered due to the company’s status, and the tax burden would unfairly fall on its shareholders. Poet responded swiftly by stating that it will redomicile in the US and shareholders can also opt for a โ€œqualified electing fundโ€ election route to lessen the adverse tax consequences.

However, what followed the very next week was even more negative and somewhat bizarre. On April 22, CFO Thomas Mika confirmed in an interview the rumors that the company had bagged an order from Marvell Technology. This supposedly violated a non-disclosure agreement Poet had with Marvell, and five days later, on April 27, Marvell canceled the order, delivering a body blow to the company.

Despite all this upheaval and negative news flow, shares of Poet are up more than 154% since April 15. Here, the deal with Lumilens certainly helped.

Source link